Robert A. Berman - 18 Dec 2024 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Chief Executive Officer, Director
Signature
/s/ Robert A. Berman
Issuer symbol
NVNO
Transactions as of
18 Dec 2024
Net transactions value
$0
Form type
4
Filing time
20 Dec 2024, 20:33:18 UTC
Previous filing
07 Dec 2023
Next filing
19 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVNO Stock Options Award $0 +200,000 $0.000000 200,000 18 Dec 2024 Common Stock 200,000 $2.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027.